Current classification and management of inflammatory myopathies

J Schmidt - Journal of neuromuscular diseases, 2018 - content.iospress.com
Inflammatory disorders of the skeletal muscle include polymyositis (PM), dermatomyositis
(DM),(immune mediated) necrotizing myopathy (NM), overlap syndrome with myositis …

Immune-mediated necrotizing myopathy

I Pinal-Fernandez, M Casal-Dominguez… - Current rheumatology …, 2018 - Springer
Abstract Purpose of Review Immune-mediated necrotizing myopathy (IMNM) is a type of
autoimmune myopathy characterized by relatively severe proximal weakness, myofiber …

239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018

AL Mammen, Y Allenbach, W Stenzel… - Neuromuscular …, 2020 - Elsevier
Idiopathic inflammatory myopathies (IIM) are a heterogenous family of diseases that can
affect the muscles, skin, lungs, and joints. There have been prior attempts to classify IIMs …

2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis …

R Aggarwal, LG Rider, N Ruperto, N Bayat… - Annals of the rheumatic …, 2017 - Elsevier
To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Expert
surveys, logistic regression, and conjoint analysis were used to develop 287 definitions …

Consensus-based recommendations for the management of juvenile dermatomyositis

FB Enders, B Bader-Meunier, E Baildam… - Annals of the …, 2017 - ard.bmj.com
Background In 2012, a European initiative called S ingle H ub and A ccess point for pediatric
R heumatology in E urope (SHARE) was launched to optimise and disseminate diagnostic …

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy

AGS Oldroyd, JB Lilleker, T Amin, O Aragon… - …, 2022 - academic.oup.com
Background Idiopathic inflammatory myopathy (IIM) is a multi-system autoimmune condition
characterised by muscle inflammation (myositis), interstitial lung disease (ILD), and skin …

JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis

L Ladislau, X Suárez-Calvet, S Toquet… - Brain, 2018 - academic.oup.com
Dermatomyositis is an acquired auto-immune disease characterized by skin lesions and
muscle-specific pathological features such as perifascicular muscle fibre atrophy and …

A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 …

I Pinal-Fernandez, M Casal-Dominguez… - …, 2017 - academic.oup.com
Objective. The aim was to study the prevalence, rate of appearance and severity of clinical
features in patients with different anti-synthetase syndrome (ASyS) autoantibodies. Methods …

Identification of distinctive interferon gene signatures in different types of myositis

I Pinal-Fernandez, M Casal-Dominguez, A Derfoul… - Neurology, 2019 - AAN Enterprises
Objective Activation of the type 1 interferon (IFN1) pathway is a prominent feature of
dermatomyositis (DM) muscle and may play a role in the pathogenesis of this disease …

Update on outcome assessment in myositis

LG Rider, R Aggarwal, PM Machado… - Nature Reviews …, 2018 - nature.com
The adult and juvenile myositis syndromes, commonly referred to collectively as idiopathic
inflammatory myopathies (IIMs), are systemic autoimmune diseases with the hallmarks of …